Recent Findings Type 2 diabetes treatment with GLP-1RA liraglutide and semaglutide paved way to a ground-breaking therapy specific for obesity, as shown with the SCALE 3 mg/day liraglutide program and the STEP 2.4 mg/week semaglutide program
GLP-1RAs also reduce food intake by modulating appetite-regulating pathways in the brain, resulting in weight loss (Koide et al., 2025) (see Figure 1)
#NationalLipidDay #LipidProfile #CardioHealth #ClinicalDiagnostics #Lifescience #HORIBA To view or add a comment, sign in Part 2: The Science Behind Bitter Kolas Health Benefits Modern research is beginning to validate what traditional users have known for centuries
The FDA found some patients drew up a higher-than-prescribed dose, with some injecting a dose five to 20 times higher than what was prescribed
When the heart switches from depending mainly on FAO to using more glucose and ketone bodies, it might further damage the myocardium
They also slow down your digestion, making you feel fuller for longer